These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 7867003)
1. Malignant transformation of the human endometrium is associated with overexpression of lactoferrin messenger RNA and protein. Walmer DK; Padin CJ; Wrona MA; Healy BE; Bentley RC; Tsao MS; Kohler MF; McLachlan JA; Gray KD Cancer Res; 1995 Mar; 55(5):1168-75. PubMed ID: 7867003 [TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor expression and proliferative activity in uterine tumours of pet rabbits. Vinci A; Bacci B; Benazzi C; Caldin M; Sarli G J Comp Pathol; 2010 May; 142(4):323-7. PubMed ID: 20096851 [TBL] [Abstract][Full Text] [Related]
3. Expression of fos and jun proto-oncogenes in benign versus malignant human uterine tissue. Nephew KP; Choi CM; Polek TC; McBride R; Bigsby RM; Khan SA; Husseinzadeh N Gynecol Oncol; 2000 Mar; 76(3):388-96. PubMed ID: 10684716 [TBL] [Abstract][Full Text] [Related]
4. Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors. Kato K; Toki T; Shimizu M; Shiozawa T; Fujii S; Nikaido T; Konishi I Int J Gynecol Pathol; 2003 Oct; 22(4):334-40. PubMed ID: 14501812 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium. Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611 [TBL] [Abstract][Full Text] [Related]
6. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions]. Ma XX; Zhang SL; Gao S; Lu JM; Dong F Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363 [TBL] [Abstract][Full Text] [Related]
7. p53lyn and p56lyn: a new signaling pathway in human endometrium and endometrial adenocarcinomas. Couchman GM; Bentley R; Tsao MS; Raszmann K; McLachlan JA; Walmer DK J Soc Gynecol Investig; 1997; 4(2):103-9. PubMed ID: 9101470 [TBL] [Abstract][Full Text] [Related]
8. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma. Götte M; Wolf M; Staebler A; Buchweitz O; Kelsch R; Schüring AN; Kiesel L J Pathol; 2008 Jul; 215(3):317-29. PubMed ID: 18473332 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical estrogen receptor assessment in hyperplastic, neoplastic, and physiologic endometria. Huang SJ; Cheng L; Lewin KJ; Fu YS Pathol Res Pract; 1991 May; 187(4):487-95. PubMed ID: 1876529 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of HER-2/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometrium. Bigsby RM; Li AX; Bomalaski J; Stehman FB; Look KY; Sutton GP Obstet Gynecol; 1992 Jan; 79(1):95-100. PubMed ID: 1345772 [TBL] [Abstract][Full Text] [Related]
12. Retinoid receptors in the human endometrium and its disorders: a possible modulator of 17 beta-hydroxysteroid dehydrogenase. Ito K; Suzuki T; Moriya T; Utsunomiya H; Sugawara A; Konno R; Sato S; Sasano H J Clin Endocrinol Metab; 2001 Jun; 86(6):2721-7. PubMed ID: 11397877 [TBL] [Abstract][Full Text] [Related]
13. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium. Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical and in situ hybridization analysis of p53 in human endometrial carcinoma of the uterus. Jiko K; Sasano H; Ito K; Ozawa N; Sato S; Yajima A Anticancer Res; 1993; 13(2):305-10. PubMed ID: 8517643 [TBL] [Abstract][Full Text] [Related]
15. Expression of cold-inducible RNA-binding protein in the normal endometrium, endometrial hyperplasia, and endometrial carcinoma. Hamid AA; Mandai M; Fujita J; Nanbu K; Kariya M; Kusakari T; Fukuhara K; Fujii S Int J Gynecol Pathol; 2003 Jul; 22(3):240-7. PubMed ID: 12819390 [TBL] [Abstract][Full Text] [Related]
16. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer. Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630 [TBL] [Abstract][Full Text] [Related]
17. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma. Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755 [TBL] [Abstract][Full Text] [Related]
18. Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma. Kurai M; Shiozawa T; Shih HC; Miyamoto T; Feng YZ; Kashima H; Suzuki A; Konishi I Hum Pathol; 2005 Dec; 36(12):1281-8. PubMed ID: 16311121 [TBL] [Abstract][Full Text] [Related]
19. Oestrogen and progesterone receptor immunocytochemistry in human hyperplastic and neoplastic endometrium. Snijders MP; de Goeij AF; Koudstaal J; Thunnissen EB; de Haan J; Bosman FT J Pathol; 1992 Feb; 166(2):171-7. PubMed ID: 1560318 [TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of gonadotropin-releasing hormone receptor in the endometrium of normal and endometrial cancer uterus]. Yue Y; Piao JX; Wang LN; Pu JW; Gao FD Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):326-8. PubMed ID: 16762189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]